Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Defense was posted on April 28, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Non-Human Primate Training Simulator

Closed
W81XWH-21-S-0002Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Grant
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
Solicitation # RFA-AI-28-012
The National Institute of Allergy and Infectious Diseases (NIAID) has issued solicitation RFA-AI-28-012 to establish a consortium of Translational Centers Using Microphysiological Systems for Infectious Diseases (TCMID). The primary objective is to refine and validate human tissue models using Microphysiological Systems (MPS) to a level consistent with regulatory qualifications, thereby promoting their adoption by product developers and reducing reliance on laboratory animals. This initiative aligns with NIH and FDA guidance on New Approach Methodologies (NAMs) to accelerate the development of safer medical interventions by capturing human variability and patient-specific characteristics. The program is structured around an Administrative Core, a Qualification Core, and Scientific Cores, with a heavy emphasis on technical readiness, reproducibility, and regulatory acceptance. Key deliverables include the validation of assays for specific endpoints and the submission of regulatory packages. Applicants must be domestic entities, as foreign organizations and foreign subawards are strictly prohibited. Required personnel must possess deep expertise in infectious diseases, MPS platforms, bioinformatics, and FDA submission processes. Applications are due by January 29, 2027, and must be submitted via the NIH ASSIST system or approved institutional system-to-system solutions. Evaluation is based on an overall impact score considering the project's significance, the suitability of the investigators, and the quality of the institutional environment. Mandatory application components include a Data Management and Sharing Plan and a Benchmarks and Timeline PDF not exceeding six pages. Awardees must also adhere to strict cybersecurity incident reporting guidelines, notifying HHS within 48 hours of any discovery.
National Institutes Of Health

POSTED

about 19 hours ago

DEADLINE

in 3 months
NAICS: 541714
New
Grant
Immune Tolerance Network (UM1 Clinical Trial Required)
Solicitation # RFA-AI-28-005
The National Institutes of Health, under the Department of Health and Human Services, is seeking applications through solicitation RFA-AI-28-005 to continue the Immune Tolerance Network (ITN). This cooperative agreement aims to develop tolerogenic therapies for immune-mediated disorders, specifically focusing on autoimmune diseases, allergic diseases and asthma, and the immune-mediated consequences of transplantation. The network operates through four integrated functional areas: Leadership, Clinical Operations, Core Laboratory, and Bioinformatics. Its primary objectives include designing and conducting clinical trials, performing integrated mechanistic studies, and sharing research results. Eligible applicants include small businesses and other for-profit organizations, though non-domestic entities are ineligible. Applications are evaluated based on scientific and technical merit, with a primary focus on significance and the likelihood of exerting a sustained influence on the research field. Key requirements include maintaining active registrations in SAM.gov, eRA Commons, and Grants.gov, as well as adhering to strict cybersecurity incident reporting and human subject protection protocols. The project requires a minimum effort of 3.6 person months per year for the PD/PI and mandates participation in a kick-off meeting in Bethesda, Maryland, and bi-annual steering meetings. Applications must follow specific page limits for the research strategy subsections and include detailed plans for clinical trial implementation, data management, and biorepository services.
National Institutes Of Health

POSTED

about 19 hours ago

DEADLINE

in 3 months
NAICS: 541714
New
Federal
Pre-Award Synopsis Texas Shield
Solicitation # DARPA-SN-27-07
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), intends to enter into an agreement with The University of Texas System consortium of universities for the Texas Shield Program. This integrated research initiative, identified by solicitation number DARPA-SN-27-07 and NAICS code 541714, focuses on developing autonomous and semi-autonomous medical technologies and scalable solutions for critical medical consumables. The primary goal is to support lifesaving medical care in contested, austere, and resource-limited environments. Key technical areas of focus include autonomous medical and robotic surgical systems, casualty evacuation, artificial-blood and supply innovation, AI-enabled clinical decision support, and mass-casualty science and simulation. This notice is a pre-award synopsis and is not a request for proposals or a competitive solicitation. Interested entities are invited to submit information by November 15, 2026, to TexasShieldxBTO@darpa.mil detailing their technical expertise, integrated research infrastructure, clinical-validation capabilities, and multi-institutional coordination capacity. Additionally, respondents must describe their consortium organizational structure, commercialization capabilities, facility clearance levels, and their ability to handle Controlled Unclassified Information. The government will not reimburse any costs associated with the preparation or submission of information in response to this notice.
Defense Advanced Research Projects Agcy

POSTED

4 days ago

DEADLINE

in 26 days
NAICS: 541714
New
Federal
Q--AMPLICON SEQUENCING SERVICES
Solicitation # 140G0226Q0047
Solicitation 140G0226Q0047 is a firm-fixed-price request for a Blanket Purchase Agreement (BPA) to provide next generation amplicon sequencing services for the USGS Upper Midwest Water Science Center’s Michigan Bacteriological Research Laboratory. The scope of work includes providing all equipment, labor, travel, and materials necessary to support research on bacterial pathogens, harmful algal blooms, microbial ecology, antibiotic resistance, and microbial source tracking. Key technical requirements include the use of Illumina MiSeq or AVITI sequencing technologies and the potential for library preparation for 16S V4 amplicon sequencing. The BPA has a total not-to-exceed value of 250,000 dollars with an estimated period of performance from September 17, 2026, to September 16, 2031. The award process prioritizes non-priced factors significantly over cost, focusing on the offeror's qualifications and technical performance. Evaluation criteria include a detailed listing of on-site equipment and calibration dates, personnel experience, internal quality assurance procedures, and a technical narrative not exceeding two pages. Performance will be executed in Lansing, Michigan, with delivery terms set as FOB Destination. Administrative requirements include electronic invoicing via the Internet Payment Platform and compliance with various federal regulations, including the Buy American Act and specific security prohibitions regarding telecommunications equipment. Proposals must be submitted to the USGS OAG Denver Acquisition Branch by September 11, 2026.
Ofc Of Acquisition Grants-Denver

POSTED

4 days ago

DEADLINE

in 3 days

General Info

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → W4PZ USA Medical Rsch Acquis Act
Contacts2 people available
OfficeFORT DETRICK, MD, 21702-5014, USA
Office AddressFORT DETRICK, MD, 21702-5014, USA

Full Description

Show more
MARKET SURVEY REQUEST: THIS IS A REQUEST FOR INFORMATION ONLY for market research and planning purposes only, as defined in FAR 15.201(e). This is not a solicitation or request for competitive proposals. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. No solicitation document exists or is guaranteed to be issued as a result of this Notice. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted, and the Government will not reimburse respondents for preparation of the response. Response to this Notice is strictly voluntary and will not affect future ability to submit an offer if a solicitation is released. There is no bid package or solicitation document associated with this announcement. BACKGROUND: The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is the Department of Defense's (DoD) lead laboratory for medical biological defense research. USAMRIID's core mission is to protect the warfighter from biological threats; USAMRIID also investigates disease outbreaks and threat to the public health. The research conducted at USAMRIID leads to medical solutions'therapeutics, vaccines, diagnostics, and information that benefit both the military personnel and civilians. USAMRIID has a mission to provide leading edge medical capabilities to deter and defend against current and emerging biological threat agents. REQUIREMENT: The USAMRIID Veterinary Medicine Division (VMD) requires the procurement of a Non-Human Primate (NHP) Training Simulator, which may be referenced as a NHP Trainer, NHP skills Trainer, or NHP Simulator, which will provide a comprehensive, timely solution to improve upon the VMD training program and ensure that federal regulatory requirements are maintained. The enterprise solution must support a variety of end users to include veterinarians, veterinary technicians, caretakers, PIs, and research staff. The NHP Training Simulator acquisition directly supports not only laboratory animal regulatory requirements, but also continued growth and development of the animal care technicians skillsets and supports the Army's Laboratory Animal Medicine Residency Program. Technical requirements: The Contractor shall provide a NHP Training Simulator with the following technical requirements: 1. A 4-10k full body model with state of the art skills trainer designed to replicate Macaca Fasicularis animal with training sights designed to replicate look, feel and function of medical procedures performed. 2. A system with an anatomically accurate airway. The system must permit realistic endotracheal intubation with a 4mm endotracheal tube. 3. A system with a durable, washable, replaceable coat. The system shall be designed in a way that allows USAMRIID to replace the fur, wash, and clean external elements, and durable enough to withstand repeated use in training under industry average conditions for a minimum of three (3) years. Functional requirements: The Contractor shall provide a NHP Training Simulator with the following functional requirements: 1. The system must allow phlebotomy training (femoral/saphenous/cephalic) to include incorporation of a - flash cue. 2. The system must allow intravenous catheter placement (cephalic) to include incorporation of a - flash cue. 3. The system must allow for intubation with chest rise and fall. This will allow users the ability to train on intubation procedures to include bag valve ventilation. The chest must rise and fall with accurate placement (stomach rise and fall if incorrectly placed in esophagus). 4. The system should permit advanced artificial ventilation training to include use of a ventilator. 5. The system should allow for cerebrospinal fluid (CSF) collection. The system must include anatomically correct landmarks. It should have the ability to perform lumbar (L4-5, L5-6) and cisterna magna puncture (placement confirmed by positive response) with reusable puncture inserts, followed by subsequent CSF collection training. NHP SIMULATOR TRAINING: The Contractor shall provide on-site training on the NHP Training Simulator use and sustainment. The training dates and times will be agreed upon both the Government and the Contractor after the NHP Simulator has been provided and reviewed by USAMRIID's Property Book Office and Clinical Engineering. NHP training SIMULATOR consumables AND OPERATING MANUAL: The Contractor shall supply a basic set of consumables used during normal operation of the NHP Training Simulator upon initial delivery. 1. The Contractor shall provide an Operating Manual to allow a user to operate the system in the absence of the Contractor. The Operating Manual shall include the following: 2. Comprehensive instructions for unpacking, setup, calibration (if required), power up, operating instructions (covering all features), power down, storage, maintenance, troubleshooting of the system and system part numbers. 3. The Operating Manual shall also outline safety guidelines for operating the system, quick start guide, and service instructions (covering all services to maintain the system in the field). SUBMITTALS: Summaries of the services as listed above shall be no more than Ten (10) pages in length (1 side of 1 sheet of paper counts as a - Page), and shall describe service capabilities in each of these areas. Interested Parties shall provide their business size status based upon NAICS code 541714, Research and Development in Biotechnology (except Nano-Biotechnology), with a Small Business Size Standard of 1,000 Employees, and their CAGE code as registered at beta.sam.gov. Interested Parties may include item brochure information with the summary package by the Government's requested date of submittal of 13 May 2021. Interested parties shall submit information in response to this RFI to: jennifer.s.bassett.civ@mail.mil. Responses shall be submitted and received via Email no later than Two O'clock Post Meridian Eastern Standard Time (2:00PM EST) Thursday, 13 May 2021 Documents shall be electronic in Microsoft Word, Excel, Power Point, and/or Adobe Portable Document Format (PDF) and provided as attachments to the Email. No telephonic responses to this RFI will be considered. Questions concerning this Request For Information (RFI) may be addressed by contacting: jennifer.s.bassett.civ@mail.mil. All information received in response to this RFI that is marked proprietary will be handled accordingly. Responses to this RFI are not offers for a contract and will not be used by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. Vendors having the services that they believe would be suitable for operations as described herein shall submit all supporting documentation requested by this RFI to the Point of Contact (POC) noted above. Please provide information on your organization in the following areas: 1. Company Name, Address and Single Point of Contact with Name, Title, Telephone Number and E-mail Address. 2. DUNS Number and Cage Code 3. Confirmation of Current Active Registration in System for Award Management (SAM) 4. Primary NAICS Code(s) and Business Size (i.e., small/large) 5. GSA Schedule, If Available 6. Commercial Price List, if GSA schedule is Not Available 7. Product Specific Brochures Literature PROVISIONS AND CLAUSES: 52.215-3 Request for Information or Solicitation for Planning Purposes. Request for Information or Solicitation for Planning Purposes (Oct 1997) (a) The Government does not intend to award a contract on the basis of this solicitation or to otherwise pay for the information solicited except as an allowable cost under other contracts as provided in subsection 31.205-18, Bid and proposal costs, of the Federal Acquisition Regulation. (b) Although "proposal" and "Offeror" are used in this Request for Information, your response will be treated as information only. It shall not be used as a proposal. (c) This solicitation is issued for the purpose of: NON-HUMAN PRIMATE TRAINING SIMULATOR (End of provision)

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS